RELVAR

Relvar Ellipta 200/25 mcg Inhaler (30 doses) is a prescription medication designed to provide relief from chronic obstructive pulmonary disease (COPD) and asthma. This inhaler combines two active ingredients, fluticasone furoate (a corticosteroid) and vilanterol (a long-acting beta-agonist), to reduce inflammation, open airways, and improve breathing. The fluticasone component works to decrease inflammation in the airways, preventing symptoms like wheezing, shortness of breath, and coughing. The vilanterol component helps to relax the muscles around the airways, making it easier to breathe. This combination therapy provides long-term control for individuals with COPD or asthma, helping to prevent flare-ups and improve overall lung function. Relvar Ellipta is easy to use with a once-daily dose, offering convenience and reliability for individuals who need consistent treatment for their respiratory condition. With 30 doses in each inhaler, it provides a month-long supply of effective symptom management.